138 related articles for article (PubMed ID: 38743323)
1. Rhein suppresses esophageal cancer development by regulating cell cycle through DNMT3B gene.
Li C; Yu J; Feng Y; Sun X; Sun M; Ni W; Shao J; Wang B
Med Oncol; 2024 May; 41(6):153. PubMed ID: 38743323
[TBL] [Abstract][Full Text] [Related]
2. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
Yu-Jing T; Wen-Jing T; Biao T
Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
4. [Auxiliary diagnosis and prognosis evaluation of KIF4A, RAD51AP1 and CDKN3 in esophageal cancer].
Qiu S; Guo CX; Li L; Yuan JF; Liu J; Peng YY; Qiu Q
Zhonghua Yu Fang Yi Xue Za Zhi; 2024 May; 58(5):665-672. PubMed ID: 38715507
[TBL] [Abstract][Full Text] [Related]
5. APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis.
Cao X; Wu B; Guo S; Zhong W; Zhu S; Zhang Z; Gu L; Li H
Pathol Oncol Res; 2023; 29():1610976. PubMed ID: 36969562
[No Abstract] [Full Text] [Related]
6. Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology.
Zhou W; Wu J; Zhang J; Liu X; Guo S; Jia S; Zhang X; Zhu Y; Wang M
Sci Rep; 2020 Jul; 10(1):12745. PubMed ID: 32728182
[TBL] [Abstract][Full Text] [Related]
7. Systematic investigation of the clinical significance and prognostic value of the CBXs in esophageal cancer.
Hou J; Yang Y; Gao H; Ouyang T; Liu Q; Ding R; Kan H
Medicine (Baltimore); 2022 Oct; 101(40):e30888. PubMed ID: 36221371
[TBL] [Abstract][Full Text] [Related]
8. Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.
Zeng JH; Xiong DD; Pang YY; Zhang Y; Tang RX; Luo DZ; Chen G
Oncotarget; 2017 May; 8(22):35681-35699. PubMed ID: 28415685
[TBL] [Abstract][Full Text] [Related]
9. Screening of four key genes in esophageal carcinoma based on TCGA and GEO data and verification of anti-proliferative effect of LAPTM4B knockdown in esophageal carcinoma cells invitro.
Guo K; Li K
Arch Biochem Biophys; 2022 Oct; 728():109352. PubMed ID: 35863479
[TBL] [Abstract][Full Text] [Related]
10. [Active ingredients in rhubarb with anti-proliferative effects on scar fibroblasts].
Wang Q; Zhang NN; Li HY; Jiang M; Gao J; Bai G
Yao Xue Xue Bao; 2012 Dec; 47(12):1618-22. PubMed ID: 23460967
[TBL] [Abstract][Full Text] [Related]
11. Multi-Omics Analysis Reveals the IFI6 Gene as a Prognostic Indicator and Therapeutic Target in Esophageal Cancer.
Viet-Nhi NK; Minh Quan T; Cong Truc V; Anh Bich T; Hoang Nam P; Le NQK; Chen PY; Hung SH
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473938
[TBL] [Abstract][Full Text] [Related]
12. Caprin-1 plays a role in cell proliferation and Warburg metabolism of esophageal carcinoma by regulating METTL3 and WTAP.
Gao Y; Yuan L; Ke C; Pei Z; Liu X; Wu R; Kui X; Zhang Y
J Transl Med; 2023 Feb; 21(1):159. PubMed ID: 36855123
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics Analysis of Autophagy-related lncRNAs in Esophageal Carcinoma.
Wu D; Ding Y; Fan J
Comb Chem High Throughput Screen; 2022; 25(8):1374-1384. PubMed ID: 34170806
[TBL] [Abstract][Full Text] [Related]
14. Rhein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma BEL-7402 cells.
Shi P; Huang Z; Chen G
Am J Chin Med; 2008; 36(4):805-13. PubMed ID: 18711776
[TBL] [Abstract][Full Text] [Related]
15. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
Wu K; Zhang C; Zhang C; Dai D
Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700
[TBL] [Abstract][Full Text] [Related]
16. Screening and verification of potential gene targets in esophageal carcinoma by bioinformatics analysis and immunohistochemistry.
Wen P; Dayyani F; Tao R; Zhong X
Ann Transl Med; 2022 Jan; 10(2):70. PubMed ID: 35282073
[TBL] [Abstract][Full Text] [Related]
17. Functional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma.
Liu XS; Liu ZY; Zeng DB; Hu J; Chen XL; Gu JL; Gao Y; Pei ZJ
Aging (Albany NY); 2024 Feb; 16(4):3934-3954. PubMed ID: 38382106
[TBL] [Abstract][Full Text] [Related]
18. DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.
Megiorni F; Camero S; Ceccarelli S; McDowell HP; Mannarino O; Marampon F; Pizer B; Shukla R; Pizzuti A; Marchese C; Clerico A; Dominici C
Oncotarget; 2016 Nov; 7(48):79342-79356. PubMed ID: 27764816
[TBL] [Abstract][Full Text] [Related]
19. Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies.
Yu XW; She PW; Chen FC; Chen YY; Zhou S; Wang XM; Lin XR; Liu QL; Huang ZJ; Qiu Y
BMC Cancer; 2024 Feb; 24(1):230. PubMed ID: 38373930
[TBL] [Abstract][Full Text] [Related]
20. Development of Multiscale Transcriptional Regulatory Network in Esophageal Cancer Based on Integrated Analysis.
Xu Z; Wu Z; Zhang J; Zhou R; Wu J; Yu B
Biomed Res Int; 2020; 2020():5603958. PubMed ID: 32851080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
